MedPath

洛阳新春都生物制药有限公司

Ownership
-
Established
2004-05-09
Employees
-
Market Cap
-
Website
http://www.xinchundu.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

44

NMPA:44

Drug Approvals

红他丁牌红曲胶囊

Approval Number
国食健注G20130355
Approval Date
Feb 20, 2021
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H41023765
Approval Date
May 21, 2020
NMPA

Acetylspiramycin Tablets

Product Name
乙酰螺旋霉素片
Approval Number
国药准字H41023768
Approval Date
May 21, 2020
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H41023764
Approval Date
May 21, 2020
NMPA

牛黄解毒片

Approval Number
国药准字Z41020621
Approval Date
May 21, 2020
NMPA

板蓝根颗粒

Approval Number
国药准字Z41020620
Approval Date
May 21, 2020
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H41020889
Approval Date
May 21, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H41020884
Approval Date
May 21, 2020
NMPA

Compound Hepar Extractum Tablets

Product Name
复方肝浸膏片
Approval Number
国药准字H41024808
Approval Date
May 21, 2020
NMPA

Ribavirin Tablets

Product Name
利巴韦林片
Approval Number
国药准字H19999541
Approval Date
May 21, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.